Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anurag Saraf, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Saraf A, Roberts HJ, Wo JY, Parikh AR. Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor Location. J Natl Compr Canc Netw. 2022 10; 20(10):1177-1184. PMID: 36240854.
    Citations:    Fields:    Translation:Humans
  2. Plana D, Shung DL, Grimshaw AA, Saraf A, Sung JJY, Kann BH. Randomized Clinical Trials of Machine Learning Interventions in Health Care: A Systematic Review. JAMA Netw Open. 2022 09 01; 5(9):e2233946. PMID: 36173632; PMCID: PMC9523495.
    Citations:    Fields:    Translation:Humans
  3. Hosny A, Bitterman DS, Guthier CV, Qian JM, Roberts H, Perni S, Saraf A, Peng LC, Pashtan I, Ye Z, Kann BH, Kozono DE, Christiani D, Catalano PJ, Aerts HJWL, Mak RH. Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study. Lancet Digit Health. 2022 09; 4(9):e657-e666. PMID: 36028289; PMCID: PMC9435511.
    Citations:    Fields:    Translation:Humans
  4. Saraf A, Trippa L, Rahman R. Novel Clinical Trial Designs in Neuro-Oncology. Neurotherapeutics. 2022 Aug 15. PMID: 35969361.
    Citations:    Fields:    
  5. Milligan M, Saraf A, Perni S. Medical Misinformation: Trainees on the Starting Line of Truth. Acad Med. 2022 07 01; 97(7):943-944. PMID: 34469352.
    Citations:    Fields:    Translation:Humans
  6. Saraf A, Yock TI, Niemierko A, Oh KS, Curry WT, Butler WE, Arrillaga-Romany I, Ebb DH, Tarbell NJ, MacDonald S, Loeffler JS, Shih HA. Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: a contemporary single-institution experience. Neuro Oncol. 2022 Jun 07. PMID: 35671386.
    Citations:    Fields:    
  7. Saraf A, Pike LRG, Franck KH, Horick NK, Yeap BY, Fullerton BC, Wang IS, Abazeed ME, McKenna MJ, Mehan WA, Plotkin SR, Loeffler JS, Shih HA. Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical Trial. Neurosurgery. 2022 05 01; 90(5):506-514. PMID: 35229827; PMCID: PMC9514734.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  8. Jones BM, Lehrer EJ, Saraf A, Shafaee Z, Resende Salgado L, Osborn VW. Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter. Curr Oncol. 2022 02 16; 29(2):1150-1162. PMID: 35200597; PMCID: PMC8870882.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  9. Kamran SC, McClatchy DM, Pursley J, Trofimov AV, Remillard K, Saraf A, Ghosh A, Thabet A, Sutphin P, Miyamoto DT, Efstathiou JA. Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy. Pract Radiat Oncol. 2022 Mar-Apr; 12(2):135-144. PMID: 34619374.
    Citations: 1     Fields:    Translation:Humans
  10. Perni S, Saraf A, Milligan M. The Resident Room. Pract Radiat Oncol. 2021 May-Jun; 11(3):e252-e253. PMID: 33676033.
    Citations:    Fields:    
  11. Perni S, Saraf A, Milligan M, Oladeru OT, Franco I, Elmore SNC. A Paradigm Shift in Radiation Oncology Training. Adv Radiat Oncol. 2021 Mar-Apr; 6(2):100599. PMID: 33732957.
    Citations:    
  12. Franco I, Oladeru OT, Saraf A, Liu KX, Milligan M, Zietman A, Nguyen PL, Hirsch AE, Jimenez RB. Improving Diversity and Inclusion in the Post-Coronavirus Disease 2019 Era Through a Radiation Oncology Intensive Shadowing Experience (RISE). Adv Radiat Oncol. 2021 Jan-Feb; 6(1):100566. PMID: 32984656; PMCID: PMC7505821.
    Citations: 5     
  13. Perni S, Milligan MG, Saraf A, Vivenzio T, Marques A, Baker MA, Kosak T, Bartlett S, Physic MA, Batchelder MR, McBride S, Bredfeldt J, Cail DW, Kearney MC, Whitehouse C, Orio P, Walsh G, Haas-Kogan DA, Martin NE. Treating the SARS-CoV-2-positive patient with cancer: A proposal for a pragmatic and transparent ethical process. Cancer. 2020 09 01; 126(17):3896-3899. PMID: 32463478; PMCID: PMC7283895.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  14. Yanagihara TK, McFaline-Figueroa JR, Giacalone NJ, Lee AW, Soni V, Hwang ME, Hsieh KT, Saraf A, Wu CC, Yang D, Wen PY, Ashamalla H, Aizer AA, Wang TJC, Huang RY. A low percentage of metastases in deep brain and temporal lobe structures. Neuro Oncol. 2019 05 06; 21(5):640-647. PMID: 30715520; PMCID: PMC6502494.
    Citations: 5     Fields:    Translation:Humans
  15. Smith DR, Bian Y, Wu CC, Saraf A, Tai CH, Nanda T, Yaeh A, Lapa ME, Andrews JIS, Cheng SK, McKhann GM, Sisti MB, Bruce JN, Wang TJC. Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases. J Neurooncol. 2019 May; 143(1):145-155. PMID: 30874953.
    Citations: 3     Fields:    Translation:Humans
  16. Kristin Hsieh, Mark E. Hwang, Gabrielle Estevez-Inoa, Akshay V. Save, Anurag Saraf, Catherine S. Spina, Simon K. Cheng, Tony J. C. Wang & Cheng-Chia Wu . Temporalis muscle width as a measure of sarcopenia correlates with overall survival in patients with newly diagnosed glioblastoma. 2019; (8):379-387. View Publication.
  17. Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A, Lapa ME, Andrews JIS, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJ. Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases. CNS Oncol. 2018 01; 7(1):25-34. PMID: 29392968.
    Citations: 3     Fields:    Translation:Humans
  18. Liu YL, Saraf A, Catanese B, Lee SM, Zhang Y, Connolly EP, Kalinsky K. Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population. Breast Cancer Res Treat. 2018 01; 167(1):277-288. PMID: 28948418; PMCID: PMC5790631.
    Citations: 8     Fields:    Translation:Humans
  19. Saraf A, Grubb CS, Hwang ME, Tai CH, Wu CC, Jani A, Lapa ME, Andrews JIS, Vanderkelen S, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJC. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development. J Neurooncol. 2017 Sep; 134(2):453-463. PMID: 28674973.
    Citations: 7     Fields:    Translation:Humans
  20. Wu CC, Wuu YR, Jani A, Saraf A, Tai CH, Lapa ME, Andrew JIS, Tiwari A, Saadatmand HJ, Isaacson SR, Cheng SK, Wang TJC. Whole-brain Irradiation Field Design: A Comparison of Parotid Dose. Med Dosim. 2017 Summer; 42(2):145-149. PMID: 28479012.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  21. Liu YL, Saraf A, Lee SM, Zhong X, Hibshoosh H, Kalinsky K, Connolly EP. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat. 2016 06; 157(3):555-64. PMID: 27225388; PMCID: PMC5337480.
    Citations: 13     Fields:    Translation:Humans
  22. Wu CC, Wang TJC, Jani A, Estrada JP, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb CS, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, McKhann GM. A Modern Radiotherapy Series of Survival in Hispanic Patients with Glioblastoma. World Neurosurg. 2016 Apr; 88:260-269. PMID: 26746331; PMCID: PMC7255496.
    Citations: 4     Fields:    Translation:Humans
  23. Wang TJC, Wu CC, Jani A, Estrada J, Ung T, Chow DS, Soun JE, Saad S, Qureshi YH, Gartrell R, Saadatmand HJ, Saraf A, Garrett MD, Grubb C, Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB, Iwamoto FM, McKhann GM. Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma. Pract Radiat Oncol. 2016 Sep-Oct; 6(5):306-314. PMID: 26952813.
    Citations: 8     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Saraf's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.